Pure Global

CK-MB Rapid Quantitative Test - India CDSCO Medical Device Registration

CK-MB Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000035_839efcc2b83906b56051f06e33530ec2_b905c589b8e97f64ba9e9f71306c3001. The license holder is DIYA SCIENTIFIC, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
CK-MB Rapid Quantitative Test
UID: IMP/IVD/2022/000035_839efcc2b83906b56051f06e33530ec2_b905c589b8e97f64ba9e9f71306c3001

License Holder

DIYA SCIENTIFIC

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Biotime CK-MB ##PLACEHOLDER_0## Rapid Quantitative Test is intended to quantify the concentration of CK-MB in human serum or plasma on Biotime FIA Analyzer by fluorescent immunoassay. It is used as an aid detection of acute myocardial infarction

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Similar Products (1)
Other products with the same name or brand